Clinical Trial Update: Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of liquid and lyophilized formulations of a trivalent Group B Streptococcus vaccine; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal
• Streptococcal Infections

Drugs mentioned

• Group B Streptococcus Trivalent Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2017-07-28